Company Profiles

driven by the PitchBook Platform

Agenovir

Description

Developer of novel therapeutics. The company specializes in developing a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs.

2014

Founded

PRIVATE

Status

Series A

Latest Deal Type

$10.6M

Latest Deal Amount

$10.6M

Total Amount Raised

5

Investors

Description

Developer of novel therapeutics. The company specializes in developing a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs.

Website:

www.agenovir.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

29 Oyster Point Boulevard 3rd Floor South San Francisco, CA 94080United States +1 (650) 491-9624
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Agenovir's full profile, request a free trial.

Agenovir Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Agenovir Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Agenovir Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
California Institute for Quantitative BiosciencesAccelerator/Incubator000 0000000 0000
CelgeneCorporationMinority000 0000000 0000
Data CollectiveVenture CapitalMinority000 0000000 0000
JLABSAccelerator/Incubator000 0000000 0000
Lightspeed Venture PartnersVenture CapitalMinority000 0000000 0000
California Institute for Quantitative Biosciences Accelerator/Incubator
Celgene Corporation
Data Collective Venture Capital
JLABS Accelerator/Incubator
Lightspeed Venture Partners Venture Capital

Agenovir Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Dirk Thye MDChief Executive Officer, President and Board Member
Bolyn Hubby Ph.DChief Scientific Officer
Angela WuCo-Founder & Advisor
Dirk Thye MD Chief Executive Officer, President and Board Member
Bolyn Hubby Ph.D Chief Scientific Officer
Angela Wu Co-Founder & Advisor

Agenovir Board Members (4)

NameRepresentingRoleSinceContact
Info
Bruce Hironaka JDAgenovirDirector000 0000
Matthew OckoData CollectiveCo-Managing Partner000 0000
Stephen Quake Ph.DAgenovirCo-Founder & Chairman of the Scientific Advisory Board000 0000
William SmithAgenovirBoard Member000 0000
Bruce Hironaka JD Director Agenovir
Matthew Ocko Co-Managing Partner Data Collective
Stephen Quake Ph.D Co-Founder & Chairman of the Scientific Advisory Board Agenovir
William Smith Board Member Agenovir
Request full access to PitchBook